Devyn Smith, Arbor Biotechnologies CEO

Ex­clu­sive: Feng Zhang CRISPR start­up gath­ers patents, lock­ing up rights to fam­i­ly of edit­ing tech

In the bid to lock up patent rights to a grow­ing suite of gene edit­ing tech­nolo­gies, Ar­bor Biotech­nolo­gies has ac­quired a small start­up found­ed by …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.